TPH2 gene variants and anxiety during alcohol detoxification outcome

Psychiatry Research

Volumn 167, Issue 1-2, 2009, Pages 106-114

  Serretti, Alessandro ^a   Liappas, Ioannis ^b   Mandelli, Laura ^a   Albani, Diego ^c   Forloni, Gianluigi ^c   Malitas, Petros ^d   Piperi, Christina ^e   Politis, Antonis ^b   Tzavellas, Elias O ^b   Papadopoulou Daifoti, Zeta ^e   Zisaki, Aikaterini ^e   Prato, Francesca ^c   Batelli, Sara ^c   Polito, Letizia ^c   De Ronchi, Diana ^a   Kalofoutis, Anastasios ^d,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d European Centre for the Quality of Life ECQuaL   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alcoholism; Anxiety; Depression; Pharmacogenetic; Serotonin

Indexed keywords

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; HAMILTON ANXIETY SCALE; HAPLOTYPE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOM; TPH2 GENE;

ALCOHOLISM; ANXIETY DISORDERS; CHROMOSOME MAPPING; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRYPTOPHAN HYDROXYLASE;

EID: 64649088750     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.12.006     Document Type: Article

References (43)

1. Anthenelli R.M., and Schuckit M.A. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment. Journal of Addictive Diseases 12 (1993) 73-87
2. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., and Hariri A.R. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Molecular Psychiatry 10 (2005) 884-8, 805
3. Canli T., Congdon E., Gutknecht L., Constable R.T., and Lesch K.P. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. Journal of Neural Transmission 112 (2005) 1479-1485
4. Cavalli Sforza L. The History and Geography of Human Genes (1994), Princeton University Press, Princeton, New Jersey, USA
5. Cooper J. The Leyton obsessional inventory. Psychological Medicine 1 (1970) 48-64
6. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey 8-14
7. Dick D.M., and Foroud T. Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcoholism, Clinical and Experimental Research 27 (2003) 868-879
8. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33 (1976) 766-771
9. Goldman D., Oroszi G., O'Malley S., and Anton R. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms. Journal of Studies on Alcohol. Supplement (2005) 56-64 discussion 33
10. Gutknecht L., Jacob C., Strobel A., Kriegebaum C., Muller J., Zeng Y., Markert C., Escher A., Wendland J., Reif A., Mossner R., Gross C., Brocke B., and Lesch K.P. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. International Journal of Neuropsychopharmacol 10 (2007) 309-320
11. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 32 (1959) 50-55
12. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
13. Hesselbrock M.N., Meyer R.E., and Keener J.J. Psychopathology in hospitalized alcoholics. Archives of General Psychiatry 42 (1985) 1050-1055
14. Johnson M.E., Brems C., Mills M.E., and Fisher D.G. Psychiatric symptomatology among individuals in alcohol detoxification treatment. Addictive Behaviors 32 (2007) 1745-1752
15. Kendler K.S. "A gene for...": the nature of gene action in psychiatric disorders. American Journal of Psychiatry 162 (2005) 1243-1252
16. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., and Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54 (1997) 313-321
17. Kulikov A.V., Osipova D.V., Naumenko V.S., and Popova N.K. The C1473G polymorphism in the tryptophan hydroxylase-2 gene and intermale aggression in mice. Doklady. Biological Sciences 402 (2005) 208-210
18. Lepine J.P., and Pelissolo A. Social phobia and alcoholism: a complex relationship. Journal of Affective Disorders 50 Suppl 1 (1998) S23-S28
19. Lesch K.P. Serotonergic gene inactivation in mice: models for anxiety and aggression?. Novartis Foundation symposium 268 (2005) 111-140 discussion 140-6, 167-70
20. Li T.K. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. Journal of Studies on Alcohol 61 (2000) 5-12
21. Liappas J., Paparrigopoulos T., Tzavellas E., and Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Dependence 68 (2002) 215-220
22. Liappas J., Paparrigopoulos T., Tzavellas E., and Christodoulou G. Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration. Journal of Affective Disorders 76 (2003) 279-284
23. Liappas I., Piperi C., Malitas P.N., Tzavellas E.O., Zisaki A., Liappas A.I., Kalofoutis C.A., Boufidou F., Bagos P., Rabavilas A., and Kalofoutis A. Interrelationship of hepatic function, thyroid activity and mood status in alcohol-dependent individuals. In Vivo 20 (2006) 293-300
24. Liebowitz M.R. Social phobia. Modern Problems of Pharmacopsychiatry 22 (1987) 141-173
25. Marks I.M., and Mathews A.M. Brief standard self-rating for phobic patients. Behaviour Research and Therapy 17 (1979) 263-267
26. Naranjo C.A., Sellers E.M., and Lawrin M.O. Modulation of ethanol intake by serotonin uptake inhibitors. Journal of Clinical Psychiatry 47 (1986) 16-22 Suppl
27. Nelson E.C., Heath A.C., Bucholz K.K., Madden P.A., Fu Q., Knopik V., Lynskey M.T., Whitfield J.B., Statham D.J., and Martin N.G. Genetic epidemiology of alcohol-induced blackouts. Archives of General Psychiatry 61 (2004) 257-263
28. Pilowsky I. Dimensions of hypochondriasis. British Journal of Psychiatry 113 (1967) 89-93
29. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., and Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study [see comments]. Jama 264 (1990) 2511-2518
30. Reuter M., Kuepper Y., and Hennig J. Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. International Journal of Neuropsychopharmacol 10 (2007) 401-404
31. Scheuch K., Lautenschlager M., Grohmann M., Stahlberg S., Kirchheiner J., Zill P., Heinz A., Walther D.J., and Priller J. Characterization of a Functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biological Psychiatry 62 (2007) 1288-1294
32. Schuckit M.A., and Russell J.W. Clinical importance of age at first drink in a group of young men. American Journal of Psychiatry 140 (1983) 1221-1223
33. Schuckit M.A., Irwin M., and Brown S.A. The history of anxiety symptoms among 171 primary alcoholics. Journal of Studies on Alcohol 51 (1990) 34-41
34. Schuckit M.A., Tipp J.E., Bucholz K.K., Nurnberger Jr. J.I., Hesselbrock V.M., Crowe R.R., and Kramer J. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 92 (1997) 1289-1304
35. Serretti A., Liappas I., Mandelli L., Albani D., Forloni G., Malitas P., Piperi C., Zisaki A., Tzavellas E.O., and Papadopoulou-Daifoti Z. Interleukin-1 alpha and beta, TNF-alpha and HTTLPR gene variants study on alcohol toxicity and detoxification outcome. Neuroscience Letters 406 (2006) 107-112
36. Sifneos P. The prevalence of alexithymic characteristics in psychosomatic patients. Psychotherapy and Psychosomatics 22 (1973) 255-262
37. StatSoft, I., 1995. STATISTICA per Windows, StatSoft Italia srl.
38. Stoltenberg S.F., Glass J.M., Chermack S.T., Flynn H.A., Li S., Weston M.E., and Burmeister M. Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatric Genetics 16 (2006) 35-38
39. Syapin P.J. Alcohol and nitric oxide production by cells of the brain. Alcohol 16 (1998) 159-165
40. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Annals of Medicine 35 (2003) 94-121
41. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., and Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
42. Zhang X., Beaulieu J.M., Gainetdinov R.R., and Caron M.G. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cellular and Molecular Life Sciences 63 (2006) 6-11
43. Zill P., Preuss U.W., Koller G., Bondy B., and Soyka M. SNP- and haplotype analysis of the tryptophan hydroxylase 2 gene in alcohol-dependent patients and alcohol-related suicide. Neuropsychopharmacology 32 (2007) 1687-1694